%D9%85%D8%AB%D8%A8%D8%B7_%D8%B9%D8%A7%D9%85%D9%84_%D9%86%D8%AE%D8%B1_%D8%A7%D9%84%D9%88%D8%B1%D9%85TNF-BlockerTNF_inhibitorAnti-TNFInhibiteur_du_TNFTNF-alfa-remmers%D0%98%D0%BD%D0%B3%D0%B8%D0%B1%D0%B8%D1%82%D0%BE%D1%80%D1%8B_%D1%84%D0%B0%D0%BA%D1%82%D0%BE%D1%80%D0%B0_%D0%BD%D0%B5%D0%BA%D1%80%D0%BE%D0%B7%D0%B0_%D0%BE%D0%BF%D1%83%D1%85%D0%BE%D0%BB%D0%B8Zaviralci_TNF-alfaQ1536078
about
sameAs
Onset of psoriasis in patients with inflammatory bowel disease treated with anti-TNF agentsAnti-TNF agents for paediatric psoriasisAnti-TNF-α treatment for pelvic pain associated with endometriosisAnti-TNF agents for paediatric psoriasisAnti-TNF-α treatment for pelvic pain associated with endometriosisAnti-TNF-α treatment for pelvic pain associated with endometriosisTNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosisGenome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritisAttenuation of inflammatory polyarthritis in TNF transgenic mice by diacerein: comparative analysis with dexamethasone, methotrexate and anti-TNF protocolsAnti-TNF-alpha antibody allows healing of joint damage in polyarthritic transgenic miceTherapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approachesAnti-TNF-alpha therapy as a clinical intervention for periprosthetic osteolysis.Differential clinical efficacy of anti-CD4 monoclonal antibodies in rat adjuvant arthritis is paralleled by differential influence on NF-kappaB binding activity and TNF-alpha secretion of T cellsClinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximabEffect of Anti-TNF Antibodies on Clinical Response in Rheumatoid Arthritis Patients: A Meta-AnalysisDo Anti-TNF Blockers Increase the Risk of Lung Involvement in Patients with Ankylosing Spondylitis or Psoriatic Arthritis? A Systematic ReviewSystematic review of efficacy of anti-tumor necrosis factor (TNF) therapy in patients with psoriasis previously treated with a different anti-TNF agentAssociation between Genetic Polymorphisms and Response to Anti-TNFs in Patients with Inflammatory Bowel DiseaseEffects of Environmental Factors on Soluble Expression of a Humanized Anti-TNF-α scFv Antibody in Escherichia coliReview article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel diseaseReview article: applying pharmacokinetics to optimise dosing of anti-TNF biologics in acute severe ulcerative colitisAnti-TNF therapy for juvenile idiopathic arthritis-related uveitisImmunogenicity of Anti-TNF-α Biotherapies: II. Clinical Relevance of Methods Used for Anti-Drug Antibody DetectionReview article: the role of anti-TNF in the management of ulcerative colitis -- past, present and futureAnti-TNF therapy: past, present and futureDiscovery of Novel Orally Active Tetrahydro-Naphthyl-N-Acylhydrazones with In Vivo Anti-TNF-α Effect and Remarkable Anti-Inflammatory PropertiesAnti-TNF-alpha therapy and systemic vasculitis.Systematic review: genetic biomarkers associated with anti-TNF treatment response in inflammatory bowel diseasesExcess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agentsRisk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α AgentsCooperative anti-tumor effect of aspirin and TNF-related apoptosis-inducing ligandNonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppressionRole of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatmentsTrefoil factor-3 is not a useful marker of mucosal healing in Crohn's disease treated with anti-TNF-α antibodiesDifferences in reactivation of tuberculosis induced from anti-TNF treatments are based on bioavailability in granulomatous tissueAnti-TNF-alpha therapy enhances the effects of enzyme replacement therapy in rats with mucopolysaccharidosis type VIDiscovery of novel orally active anti-inflammatory N-phenylpyrazolyl-N-glycinyl-hydrazone derivatives that inhibit TNF-α productionCancer risk of anti-TNF-α at recommended doses in adult rheumatoid arthritis: a meta-analysis with intention to treat and per protocol analysesLASSBio-1135: a dual TRPV1 antagonist and anti-TNF-alpha compound orally effective in models of inflammatory and neuropathic painAnti-TNF treatment response in rheumatoid arthritis patients is associated with genetic variation in the NLRP3-inflammasome
P921
P924
Q22305935-9B221CA8-1B75-4B15-9DE2-76019CD8602EQ24187673-119B0BE8-B7F4-4F56-94D0-49F69CCB1546Q24198870-FE42F5D3-084A-43FC-97F4-6FB3FDC0DEDDQ24201907-EBFDAC43-60A1-454D-B2AC-48B0328EEB70Q24236724-89DF789A-96E4-408C-A3AC-EE86A017D2E8Q24241590-57EA2AE7-B498-46EE-800C-15EE4D65368EQ24293476-07AA6413-6C54-4045-809B-E1ED48E8D91EQ24647387-7C357571-7974-4F9C-87F9-937AC1026E21Q24793159-4062AA4A-E3ED-4BCA-A091-DD27ED935F5EQ24801075-C9705306-030C-4899-99A2-A5D08C7ACB28Q24806367-85AA472B-12A2-489C-8DDC-F97D60C5C5EAQ24806847-D78C3600-E5A6-41FC-AC0B-18CDE8399E78Q24807250-B9FA0921-009F-40CF-8CEF-25D0D5B59E8DQ24816557-FB307D46-19D8-48A0-83EB-E524D3E0904AQ26739150-273E7790-9A7C-4A98-ACE5-CBB7E27B2E0FQ26745746-228F93A8-6676-40BB-B694-4BE37663AC13Q26750530-215BE922-A839-4713-B9C0-DEC6E23BC785Q26767247-6DF54290-8213-4A12-8143-8A84D1B7E1DAQ26773076-285A9051-3B09-40F8-AD18-9BAA5EA31278Q26822029-8555F8C3-C8F9-4FA2-8EF1-F8FA5E366DFDQ26823221-69FE7C8A-DB0C-41DD-9E1D-7B2AF579C24EQ26849811-D29C65FD-1E9C-424E-8B3A-E05BDDA7FF61Q26865822-A79E2900-3A6E-4136-8599-B88CE181E1CFQ26992012-AD8FBD30-4802-4644-8D04-6D9BD9F30424Q26997311-D483DC3C-569A-48A3-B809-103755C7E52BQ27343134-4018EE5E-A5F3-4EBD-A461-351EEBFB6C8CQ27687590-AE598291-66B2-418E-B30A-DFC343853219Q28072105-500807DE-FEE7-48DE-94D1-A7A5CA061AD6Q28075692-FF062494-B9D2-43DB-AF88-949CBDFF9658Q28109332-021E0274-3FF7-4BF9-8044-87C4E5E707B9Q28166253-8313D461-7CBB-4222-96CB-96342A03FE2DQ28192264-4B75B0B7-95E5-4266-AF60-B8ABAB422897Q28200814-B9717FDF-24B1-4E9A-8F3F-8355F7A1A6A8Q28468381-2D4CC3C8-9AF0-4917-ACA7-ECC54CF0FF8AQ28469340-4C8F998B-F099-4DC5-80F4-A31F3442BAD7Q28476636-CA6BDDC4-A9B3-4F33-B703-FEE6E5983866Q28484258-2B915919-F4AA-4CE4-9035-D389BB72E509Q28485181-D16450D6-B9A0-4C65-8D7F-1A65E0C2C749Q28539803-0433F22C-BC01-4CA7-86F8-D1450C2F753AQ28540052-44236F25-DE08-465F-B80C-4E83CABF2156
P921
description
Inhibits Thromboxane, a vasoconstrictor and platelet aggregator
@en
name
Anti-TNF
@es
Inhibiteur du TNF
@fr
TNF inhibitor
@en
TNF-Blocker
@de
TNF-alfa-remmers
@nl
TNF抑制劑
@zh
Zaviralci TNF-alfa
@sl
Ингибиторы ФНО
@ru
مثبط عامل نخر الورم
@ar
肿瘤坏死因子抑制剂
@zh-hans
type
label
Anti-TNF
@es
Inhibiteur du TNF
@fr
TNF inhibitor
@en
TNF-Blocker
@de
TNF-alfa-remmers
@nl
TNF抑制劑
@zh
Zaviralci TNF-alfa
@sl
Ингибиторы ФНО
@ru
مثبط عامل نخر الورم
@ar
肿瘤坏死因子抑制剂
@zh-hans
altLabel
Anti TNF
@es
Anti TNF
@fr
Anti-TNF alpha
@fr
Anti-TNF
@fr
Inhibiteur du TNF-alpha
@fr
TNF blockers
@nl
TNF-Hemmer
@de
TNF-Inhibitor
@de
TNF-α-Blocker
@de
TNF-α-Hemmer
@de
prefLabel
Anti-TNF
@es
Inhibiteur du TNF
@fr
TNF inhibitor
@en
TNF-Blocker
@de
TNF-alfa-remmers
@nl
TNF抑制劑
@zh
Zaviralci TNF-alfa
@sl
Ингибиторы ФНО
@ru
مثبط عامل نخر الورم
@ar
肿瘤坏死因子抑制剂
@zh-hans
P6366
P646
P373
TNF-alpha inhibitors
P6366
2779722408
P646
/m/02vkhwm
P7830
TNFAntagonists